Study Stopped
Hard to enroll participants
Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy
Effect of Kidney Yin/Yang Replenishment on Bone Metabolism in Patients With Renal Osteodystrophy
1 other identifier
interventional
N/A
1 country
3
Brief Summary
Patients with serious chronic renal insufficiency usually develop secondary osteoporosis or bone loss, especially those with chronic dialysis, and the degree of bone loss is corrected with decrease of renal function. In traditional Chinese medicine, kidney function is considered to dominate bone development and metabolism. Kidney Yin and Yang replenishment will help improve bone development and metabolism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2012
Longer than P75 for phase_2
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 8, 2012
CompletedFirst Posted
Study publicly available on registry
August 15, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2017
CompletedMay 8, 2017
May 1, 2017
4.8 years
August 8, 2012
May 4, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Bone Mineral Density
3 months
Secondary Outcomes (4)
Kidney Yin and Yang evaluation
3 months
bone metabolism
3 months
Blood Urea Nitrogen
3 months
creatinine
3 months
Other Outcomes (2)
miRNA array
3 months
bone morphogenetic protein 7
3 months
Study Arms (4)
kidney Yin deficiency with placebo
PLACEBO COMPARATORchronic renal insufficiency patients with kidney Yin deficiency evaluated with traditional Chinese medicine will be given Zuogui granules placebo treatment besides basic treatment.
kidney Yang deficiency with placebo
PLACEBO COMPARATORchronic renal insufficiency patients with kidney Yang deficiency evaluated with traditional Chinese medicine will be given Yougui granules placebo treatment besides basic treatment.
kidney Yin deficiency with Zuogui
EXPERIMENTALchronic renal insufficiency patients with kidney Yin deficiency evaluated with traditional Chinese medicine will be given Zuogui granules treatment besides basic treatment.
kidney Yang deficiency with Yougui
EXPERIMENTALchronic renal insufficiency patients with kidney Yang deficiency evaluated with traditional Chinese medicine will be given Yougui granules treatment besides basic treatment.
Interventions
Yougui granules is traditional Chinese patent medicine used to treatment patients with kidney Yang deficiency. Granules, 11g/pouch, taking with water, 2 pouches, twice a day, three months.
Zuogui granules is traditional Chinese patent medicine used to treatment patients with kidney Yin deficiency. Granules, 11g/pouch, taking with water, 2 pouches, twice a day, three months.
Granules, 11g/pouch, taking with water, 2 pouches, twice a day, three months.
Granules, 11g/pouch, taking with water, 2 pouches, twice a day, three months.
Eligibility Criteria
You may qualify if:
- chronic renal insufficiency
- bone loss or osteoporosis
- years old
- kidney Yin or Yang deficiency evaluated with traditional Chinese medicine
- be willing to and be able to join in the study and signed Informed consent
- have not accepted systematical treatment on bone loss or osteoporosis
You may not qualify if:
- allergies
- secondary osteoporosis caused by other diseases.
- postmenopausal women
- mental illness or psychosis
- patients with bone fracture and need surgery treatment
- taking any medicine that will affect bone metabolism for a long time and can not stop
- women during pregnant stage and breast-feed stage
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bing Shulead
- Huadong Hospitalcollaborator
- The First Affiliated Hospital of Anhui University of Chinese Medicinecollaborator
- Longhua Hospitalcollaborator
Study Sites (3)
The first affiliated hospital of Anhui University of TCM
Hefei, Anhui, 230031, China
Huadong hospital affiliated to Fudan University
Shanghai, Shanghai Municipality, 200000, China
Longhua Hospital affiliated to Shanghai Uni of TCM
Shanghai, Shanghai Municipality, 200032, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yongjun Wang, Doctor
Longhua hospital affiliated to Shanghai Uni of TCM
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- assistant research fellow
Study Record Dates
First Submitted
August 8, 2012
First Posted
August 15, 2012
Study Start
August 1, 2012
Primary Completion
May 1, 2017
Study Completion
May 1, 2017
Last Updated
May 8, 2017
Record last verified: 2017-05